Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iqvia Holdings Inc (NY: IQV )

189.47 -1.44 (-0.75%)
Streaming Delayed Price Updated: 2:45 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 377,191
Open 189.43
Bid (Size) 189.33 (1)
Ask (Size) 189.49 (2)
Prev. Close 190.91
Today's Range 188.61 - 191.02
52wk Range 165.75 - 254.94
Shares Outstanding 185,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
These companies strive to bring down the cost of developing new therapies. 
Via The Motley Fool
(IQV) - Analyzing IQVIA Hldgs's Short Interest
 
Via Benzinga

Performance

YTD
-7.06%
-7.06%
1 Month
-9.29%
-9.29%
3 Month
-6.63%
-6.63%
6 Month
+1.82%
+1.82%
1 Year
-16.42%
-16.42%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
Via Benzinga
What 6 Analyst Ratings Have To Say About IQVIA Hldgs
Via Benzinga
Here's How Much $100 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today
Via Benzinga
Where IQVIA Hldgs Stands With Analysts
Via Benzinga
IQVIA Clocks 2.8% Sales Growth In Q4, Beats Street View By A Whisker
Via Benzinga
Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023
From IQVIA
Via Business Wire
MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
Via Benzinga
IQVIA Publishes its 2022 Environmental, Social and Governance Report
From IQVIA
Via Business Wire
Earnings Outlook For IQVIA Holdings
Via Benzinga
Will Investors Notice Exciting Sign On IQVIA Hldgs's Chart?
Via Benzinga
Got $300? 3 Growth Stocks to Buy That Could Double Your Money
Via The Motley Fool
7 Hot Healthcare Stocks With the Potential to Outperform
Via InvestorPlace
IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
From IQVIA Holdings Inc.
Via Business Wire
PayPal, Global Payments And 3 Stocks To Watch Heading Into Friday
Via Benzinga
Investor Optimism Declines Slightly As Dow Drops 250 Points
Via Benzinga
Analyst Ratings for IQVIA Hldgs
Via Benzinga
IQVIA Named to FORTUNE’s 2023 List of “World’s Most Admired Companies,” Ranked #1 in Its Category for the Second Consecutive Year
From IQVIA
Via Business Wire
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
Via The Motley Fool
IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China
From IQVIA
Via Business Wire
IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023
From IQVIA
Via Business Wire
Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA Institute
From IQVIA
Via Business Wire
World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.